{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T09:42:57Z","timestamp":1768815777275,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":2624,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Biokit"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1111\/jth.13062","type":"journal-article","created":{"date-parts":[[2015,7,23]],"date-time":"2015-07-23T02:11:08Z","timestamp":1437617468000},"page":"1806-1814","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of an heterogeneous group of patients with von Willebrand disease using an assay alternative to ristocetin induced platelet agglutination"],"prefix":"10.1016","volume":"13","author":[{"given":"F.","family":"Stufano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Baronciani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.T.","family":"Pagliari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Franchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Cozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Garcia\u2010Oya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bucciarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Boscarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7423-9864","authenticated-orcid":false,"given":"F.","family":"Peyvandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/jth.13062_bb0010","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand's disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"key":"10.1111\/jth.13062_bb0015","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-0037-1613992","article-title":"Impact, diagnosis and treatment of von Willebrand disease","volume":"84","author":"Sadler","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13062_bb0020","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1054\/blre.1999.0116","article-title":"Laboratory assessment as a critical component of the appropriate diagnosis and sub\u2010classification of von Willebrand's disease","volume":"13","author":"Favaloro","year":"1999","journal-title":"Blood Rev"},{"key":"10.1111\/jth.13062_bb0025","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra040403","article-title":"Treatment of von Willebrand's disease","volume":"351","author":"Mannucci","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13062_bb0030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2516.2004.00894.x","article-title":"The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors\u2019 Organization","volume":"10","author":"Laffan","year":"2004","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13062_bb0035","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1055\/s-0028-1103361","article-title":"The role of molecular genetics in diagnosing von Willebrand disease","volume":"34","author":"James","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.13062_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13062_bb0045","doi-asserted-by":"crossref","first-page":"10578","DOI":"10.1073\/pnas.0402041101","article-title":"Binding of platelet glycoprotein Ib\u03b1 to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13","volume":"101","author":"Nishio","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.13062_bb0050","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1111\/jth.12346","article-title":"The type 2B p. R1306W natural mutation of von Willebrand factor dramatically enhances the multimer sensitivity to shear stress","volume":"11","author":"Scaglione","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13062_bb0055","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJM198005083021902","article-title":"Heightened interaction between platelets and factor VIII\/von Willebrand factor in a new subtype of von Willebrand's disease","volume":"302","author":"Ruggeri","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13062_bb0060","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/ajcp\/96.6.723","article-title":"The rapid differentiation of type IIb von Willebrand's disease from platelet\u2010type (pseudo\u2010) von Willebrand's disease by the \u201cneutral\u201d monoclonal antibody binding assay","volume":"96","author":"Scott","year":"1991","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/jth.13062_bb0065","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1365-2141.2006.06095.x","article-title":"Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme\u2010linked immunosorbent assay\u2010based method: performances in patients with type 2B von Willebrand disease","volume":"133","author":"Caron","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13062_bb0070","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1365-2516.2002.00672.x","article-title":"Guidelines for the diagnosis and management of von Willebrand disease in Italy","volume":"8","author":"Federici","year":"2002","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13062_bb0075","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1182\/blood-2010-08-299016","article-title":"Gain\u2010of\u2010function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD","volume":"117","author":"Flood","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.13062_bb0080","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/jth.12964","article-title":"Platelet\u2010dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH","volume":"13","author":"Bodo","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13062_bb0085","first-page":"77","article-title":"A sensitive ristocetin co\u2010factor activity assay with recombinant glycoprotein Ibalpha for the diagnosis of patients with low von Willebrand factor levels","volume":"89","author":"Federici","year":"2004","journal-title":"Haematologica"},{"key":"10.1111\/jth.13062_bb0090","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00001721-200408000-00011","article-title":"A rapid assay for ristocetin cofactor activity using an automated coagulometer (ACL 9000)","volume":"15","author":"Lattuada","year":"2004","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.13062_bb0095","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1182\/blood.V82.6.1749.1749","article-title":"Elevated platelet count as a cause of abnormal von Willebrand factor multimer distribution in plasma","volume":"82","author":"Budde","year":"1993","journal-title":"Blood"},{"key":"10.1111\/jth.13062_bb0100","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1055\/s-0037-1614063","article-title":"Molecular characterization of a multiethnic group of 21 patients with type\u20103 von Willebrand disease","volume":"84","author":"Baronciani","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13062_bb0105","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood-2009-10-249102","article-title":"Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor","volume":"116","author":"Flood","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.13062_bb0110","first-page":"FC4\u201005","article-title":"Development of a newfunctional assay for von Willebrand factor binding to platelet GpIba that does not require ristocetin","volume":"30","author":"Schneppenheim","year":"2010","journal-title":"Hamostaseologie"},{"key":"10.1111\/jth.13062_bb0115","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-0037-1613765","article-title":"A reliable and reproducible ELISA method to measure ristocetin cofactor activity of von Willebrand factor","volume":"83","author":"Vanhoorelbeke","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13062_bb0120","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood-2008-04-152280","article-title":"Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients","volume":"113","author":"Federici","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.13062_bb0125","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1182\/blood.V68.1.149.149","article-title":"A new von Willebrand variant (type I, New York): increased ristocetin\u2010induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers","volume":"68","author":"Weiss","year":"1986","journal-title":"Blood"},{"key":"10.1111\/jth.13062_bb0130","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1182\/blood.V68.3.668.668","article-title":"von Willebrand's disease characterized by increased ristocetin sensitivity and the presence of all von Willebrand factor multimers in plasma","volume":"68","author":"Holmberg","year":"1986","journal-title":"Blood"},{"key":"10.1111\/jth.13062_bb0135","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1111\/j.1538-7836.2005.01638.x","article-title":"Expression studies on a novel type 2B variant of the von Willebrand factor gene (R1308L) characterized by defective collagen binding","volume":"3","author":"Baronciani","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13062_bb0140","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1160\/TH07-05-0347","article-title":"A novel von Willebrand factor mutation (I1372S) associated with type 2B\u2010like von Willebrand disease: an elusive phenotype and a difficult diagnosis","volume":"98","author":"Casonato","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13062_bb0145","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1073\/pnas.91.6.2221","article-title":"Multiple substitutions in the von Willebrand factor gene that mimic the pseudogene sequence","volume":"91","author":"Eikenboom","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.13062_bb0150","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1182\/blood-2005-03-1153","article-title":"A novel nanobody that detects the gain\u2010of\u2010function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B","volume":"106","author":"Hulstein","year":"2005","journal-title":"Blood"},{"key":"10.1111\/jth.13062_bb0155","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.bpj.2014.07.026","article-title":"Misfolding of vWF to pathologically disordered conformations impacts the severity of von Willebrand disease","volume":"107","author":"Tischer","year":"2014","journal-title":"Biophys J"},{"key":"10.1111\/jth.13062_bb0160","doi-asserted-by":"crossref","first-page":"30400","DOI":"10.1074\/jbc.M603321200","article-title":"Molecular mapping of the chloride\u2010binding site in von Willebrand Factor (VWF) energetics and conformational effects on the VWF\/ADAMTS\u201013 interaction","volume":"281","author":"De Cristofaro","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13062_bb0165","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/00313029700169365","article-title":"Laboratory assays for von Willebrand factor: relative contribution to the dagnosis of von Willebrand's disease","volume":"29","author":"Favaloro","year":"1997","journal-title":"Pathology"},{"key":"10.1111\/jth.13062_bb0170","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1111\/j.1538-7836.2009.03594.x","article-title":"Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function","volume":"7","author":"Flood","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13062_bb0175","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/ijlh.12218","article-title":"Evaluation of an automated method for measuring von Willebrand factor activity in clinical samples without ristocetin","volume":"36","author":"Graf","year":"2014","journal-title":"Int J Lab Hematol"},{"key":"10.1111\/jth.13062_bb0180","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.thromres.2014.04.033","article-title":"Comparison of von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo","volume":"134","author":"Geisen","year":"2014","journal-title":"Thromb Res"},{"key":"10.1111\/jth.13062_bb0185","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1160\/TH14-02-0108","article-title":"Performance of two new automated assays for measuring von Willebrand activity: HemosIL AcuStar and Innovance","volume":"112","author":"de Maistre","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13062_bb0190","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/MBC.0000000000000169","article-title":"Performance evaluation and multicentre study of a von Willebrand factor activity assay based on GPIb binding in the absence of ristocetin","volume":"25","author":"Patzke","year":"2014","journal-title":"Blood Coagul Fibrinolysis"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13062","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13062","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622084094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622084094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.13062\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:08:42Z","timestamp":1761534522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622084094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1538783622084094"],"URL":"https:\/\/doi.org\/10.1111\/jth.13062","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of an heterogeneous group of patients with von Willebrand disease using an assay alternative to ristocetin induced platelet agglutination","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.13062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}